Related references
Note: Only part of the references are listed.Occupational Exposure to Pesticides Affects Pivotal Immunologic Anti-Tumor Responses in Breast Cancer Women from the Intermediate Risk of Recurrence and Death
Janaina Carla da Silva et al.
CANCERS (2022)
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2021)
Progress and challenges of immunotherapy in triple-negative breast cancer
Yinxing Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
CTLA-4 Expression and Its Clinical Significance in Breast Cancer
Rodrigo Kern et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis
Ziqi Peng et al.
JOURNAL OF CANCER (2020)
QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence
Lynda Handala et al.
VIRUSES-BASEL (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
CD16+ NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes
Alexandra Frazao et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas
Ari Kassardjian et al.
PLOS ONE (2018)
Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and Plasma
C. Panis et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Active cigarette smoking and risk of breast cancer
Chelsea Catsburg et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Impact of Tumor Removal on the Systemic Oxidative Profile of Patients With Breast Cancer Discloses Lipid Peroxidation at Diagnosis as a Putative Marker of Disease Recurrence
Ana Cristina S. Herrera et al.
CLINICAL BREAST CANCER (2014)
Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer
Vanessa J. Victorino et al.
TUMOR BIOLOGY (2014)
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
C. Panis et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients
A. C. S. A. Herrera et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Trypanosoma cruzi: Effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice
Carolina Panis et al.
EXPERIMENTAL PARASITOLOGY (2011)
Circulating Soluble CTLA4 (sCTLA4) Is Elevated in Patients With Breast Cancer
Nasrollah Erfani et al.
CANCER INVESTIGATION (2010)
New Insights of CTLA-4 into Its Biological Function in Breast Cancer
H. Mao et al.
CURRENT CANCER DRUG TARGETS (2010)
Nitric Oxide Control of MYCN Expression and Multi Drug Resistance Genes in Tumours of Neural Origin
Antonio Porro et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
Interleukin-4 supports interleukin-12-induced proliferation and interferon-γ secretion in human activated lymphoblasts and T helper type 1 cells
Martin A. Kriegel et al.
IMMUNOLOGY (2006)
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
H Hochrein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
